Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma—A Discrete Choice Experiment
Version 4 2024-06-19, 19:43Version 4 2024-06-19, 19:43
Version 3 2024-06-02, 22:52Version 3 2024-06-02, 22:52
Version 2 2023-07-13, 05:55Version 2 2023-07-13, 05:55
Version 1 2023-06-29, 06:06Version 1 2023-06-29, 06:06
journal contribution
posted on 2024-06-19, 19:43authored byAnn LivingstoneAnn Livingstone, Kirsten Howard, Alexander M Menzies, Georgina V Long, Martin R Stockler, Rachael L Morton
Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma—A Discrete Choice Experiment